Veterinary Medicines Directorate

Charlotte Barber, Abigail McGlennon, Fleur Whitlock, John Grewar, Sophie Spalding, Richard Newton and Tamsin Dewé introduce a new government-funded initiative to strengthen the surveillance of antimicrobial resistance in the equine sector.

The epidemic of high pathogenicity avian influenza (HPAI) H5N1 in the United Kingdom and Northern Europe from 2021 to 2023 has dwarfed all previous incursions. This fact has driven the need to review biosecurity behaviours and perceptions of virus incursions on commercial poultry farms. This study used qualitative methods to evaluate farm managers' perceptions of biosecurity and their implementation of measures as recommended by the Animal and Plant Health Agency (APHA). Thirteen farm managers across different regions of England and Wales were recruited between May and September 2023 to take part in the study. Qualitative semi-structured interviews were held with managers to discuss various topics relating to biosecurity and avian influenza (AI). Biosecurity measures being used across the farm by managers and staff were also observed to help understand biosecurity behaviours. Interviews were transcribed and analysed to identify themes and patterns amongst the data, along with extensive notes collated during the farm visits. Findings showed that farms' use of biosecurity with respect to disinfection regimes and use of foot dips were both well cited and observed. Similarly, farm managers were all highly likely to refer to the use of farm-specific andshed-specificrubber boots, while also citing stricter requirements for visitors and delivery/maintenance. Biosecurity concerning the layout of the premises, fencing, access to changing rooms and the general age and maintenance of buildings and sheds required significant improvement across many farms. Additionally, farm managers expressed strong feelings of stress and anxiety in recent years, particularly those who had experienced an AI outbreak recently. We argue that factors such as risk perceptions, remits of control, feelings of responsibility and autonomy, and consequences on mental health, are all factors that can inform how farm managers respond to outbreaks and implement or sustain biosecurity on farms. A greater emphasis on providing regular and tailored training and educational resources for the industry would be beneficial as would further services focusing on reducing the burden on farmers' mental health. This research provides insight into the application and shortcomings of biosecurity implementation on commercial poultry farms. It also identifies farmer perceptions and experiences shaping implementation on farms. However, this highlights that the onus for improving biosecurity cannot remain solely with farm managers and workers. Further research exploring the role of other stakeholders in the industry would help bridge remaining gaps in our understanding of biosecurity implementation.

This work aims to generate the data needed to set epidemiological cut-off values for minimum inhibitory concentration (MIC) and disc-diffusion zone measurements of Vibrio anguillarum. A total of 261 unique isolates were tested, applying standard methods specifying incubation at 28°C for 24-28 h. Aggregated MIC distributions for a total of 247 isolates were determined in 9 laboratories for 11 agents. Data aggregations of the disc zone for the 10 agents analysed contained between 157 and 218 observations made by 4 to 7 laboratories. Acceptable ranges for quality control (QC) reference strains were available for 7 agents and the related multi-laboratory aggregated data were censored, excluding the data of a laboratory that failed to meet QC requirements. Statistical methods were applied to calculate epidemiological cut-off values. Cut-off values for MIC data were calculated for florfenicol (≤1 µg ml-1), gentamicin (≤4 µg ml-1), oxytetracycline (≤0.25 µg ml-1) and trimethoprim/sulfamethoxazole (≤0.125/2.38 µg ml-1). The cut-off values for disc zone data were calculated for enrofloxacin (≥29 mm), florfenicol (≥27 mm), gentamicin (≥19 mm), oxolinic acid (≥24 mm), oxytetracycline (≥24 mm) and trimethoprim/sulfamethoxazole (≥26 mm). MIC and disc-diffusion zone data for the other agents where not supported by QC, thus yielding only provisional cut-off values (meropenem, ceftazidime). Regardless of whether QC is available, some of the aggregated MIC distributions (enrofloxacin, oxolinic acid), disc zone (sulfamethoxazole), and MIC and disc-diffusion distributions (ampicillin, chloramphenicol) did not meet the statistical requirements. The data produced will be submitted to the Clinical Laboratory Standards Institute for their consideration in setting international consensus epidemiological cut-off values.

Lameness in sheep continues to be a global health, welfare and economic concern. Damaged, misshapen or overgrown feet have the potential to cause lameness either directly, or indirectly. There is a lack of understanding of the predisposing factors for different hoof conformation traits in sheep. Our exploratory study aimed to investigate the prevalence of, and risk factors for, three distinct hoof conformation traits relating to the sole and heel, hoof wall, and hoof wall overgrowth. Feet of 400 ewes from four UK commercial sheep farms were inspected at four time points across 12 months. For each conformation trait, a four-point ordinal system was used to score each individual claw, and foot-level scores were calculated. We present 92.4% of foot-level observations to be affected by ≥1 conformation traits. Whilst hoof conformation traits were correlated to some degree, a unique set of sheep-, foot- and farm-level factors were associated with each distinct conformation trait. We provide, for the first time, key insight into the multifaceted and multifactorial aetiology of hoof conformation in sheep, building upon previous landmark studies. Our results inform hypotheses for future prospective studies investigating the risk factors for adverse hoof conformation in sheep.

Simple SummaryThe bacterium Dichelobacter nodosus is the cause of footrot in sheep: a painful, contagious foot disease. Some sheep may be more susceptible to carrying D. nodosus on their feet, despite showing no signs of disease, and pose a risk to flock health and welfare. This study investigated whether misshapen or damaged feet (poor hoof conformation) were more likely to have D. nodosus present and in greater quantities than feet in good condition. Eighty-five ewes from four flocks were examined three times, on average, across a 12-month period. Poor hoof conformation traits were observed in over 92% of foot observations. Feet with poor sole and heel conformation were more likely to have higher quantities of D. nodosus than those in good conformation. Furthermore, on feet positive for D. nodosus, wall overgrowth contributed towards higher D. nodosus load. We highlight feet with aspects of poor conformation traits to covertly harbour D. nodosus. These feet could transmit D. nodosus to other feet of sheep. Increasing our understanding of D. nodosus infection is crucial in helping farmers improve management practices to reduce footrot.Dichelobacter nodosus is the causal agent of ovine footrot, a contagious disease of welfare and economic concern worldwide. Damaged feet may be subclinical carriers of D. nodosus and covertly spread infection. Accordingly, we evaluated the risk of misshapen and damaged feet on D. nodosus presence and load in four commercial UK sheep flocks. Foot-level observations and swabs (n = 972) were collected from ewes (n = 85) over 12 months. On average, ewes were sampled three times. Feet were inspected for disease and scored (good/poor) for three hoof conformation traits (sole and heel, wall, and wall overgrowth). Swabs were analysed for presence and load of D. nodosus, and mixed models were constructed. Poor hoof conformation traits were present in 92.5% of foot-level observations. Feet with poor sole and heel conformation were more likely to have higher D. nodosus loads (β = 0.19, 95% CI: 0.04–0.35) than those with good conformation. Furthermore, on feet positive for D. nodosus, wall overgrowth was associated with higher D. nodosus loads (β = 0.27, 95% CI: 0.01–0.52). Feet with aspects of poor conformation covertly harbour D. nodosus and are a source of infection. Flock management should be guided by hoof conformation to reduce disease challenge.

Swine influenza A virus (swIAV) infection causes substantial economic loss and disease burden in humans and animals. The 2009 pandemic H1N1 (pH1N1) influenza A virus is now endemic in both populations. In this study, we evaluated the efficacy of different vaccines in reducing nasal shedding in pigs following pH1N1 virus challenge. We also assessed transmission from immunized and challenged pigs to naive, directly in-contact pigs. Pigs were immunized with either adjuvanted, whole inactivated virus (WIV) vaccines or virus-vectored (ChAdOx1 and MVA) vaccines expressing either the homologous or heterologous influenza A virus hemagglutinin (HA) glycoprotein, as well as an influenza virus pseudotype (S-FLU) vaccine expressing heterologous HA. Only two vaccines containing homologous HA, which also induced high hemagglutination inhibitory antibody titers, significantly reduced virus shedding in challenged animals. Nevertheless, virus transmission from challenged to naive, in-contact animals occurred in all groups, although it was delayed in groups of vaccinated animals with reduced virus shedding.IMPORTANCE This study was designed to determine whether vaccination of pigs with conventional WIV or virus-vectored vaccines reduces pH1N1 swine influenza A virus shedding following challenge and can prevent transmission to naive in-contact animals. Even when viral shedding was significantly reduced following challenge, infection was transmissible to susceptible cohoused recipients. This knowledge is important to inform disease surveillance and control strategies and to determine the vaccine coverage required in a population, thereby defining disease moderation or herd protection. WIV or virus-vectored vaccines homologous to the challenge strain significantly reduced virus shedding from directly infected pigs, but vaccination did not completely prevent transmission to cohoused naive pigs.

Before a veterinary medicinal product (VMP) (including a vaccine) can be placed on the UK market, a large package of quality, safety and efficacy data undergoes a rigorous independent scientific assessment. Vaccines must be shown to be safe to use. Where necessary, specific warnings are added to the product literature which, when followed, will minimise the risk of any known potential adverse reactions. A rigorous assessment of user safety is conducted for each product. In the case of live zoonotic bacterial vaccines, the human pathogenicity of the vaccine strain in the …